We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MIST market cap is 47.21M. The company's latest EPS is USD -1.7825 and P/E is -0.79.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1M | 0 | 0 | 0 | 0 |
| Operating Income | -15.5M | -16.44M | -15.36M | -13.8M | -10.48M |
| Net Income | -14.95M | -16.04M | -15.08M | -13.61M | -10.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 15M | 5M | 1M |
| Operating Income | -57.88M | -50.71M | -43.07M | -59.64M | -61.1M |
| Net Income | -55.23M | -49.97M | -42.85M | -58.39M | -59.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 111.08M | 97.02M | 87.12M | 75.23M | 96M |
| Total Liabilities | 57.15M | 56.61M | 58.61M | 58.46M | 56.08M |
| Total Equity | 53.94M | 40.41M | 28.5M | 16.77M | 39.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 123.43M | 149.97M | 119.85M | 74.48M | 75.23M |
| Total Liabilities | 8.51M | 6.86M | 7.25M | 8.14M | 58.46M |
| Total Equity | 114.92M | 143.12M | 112.6M | 66.35M | 16.77M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.9M | -24.47M | -36.63M | -46.42M | -8.93M |
| Investing | 29.97M | 1.94M | -8.92M | 4.76M | -27.01M |
| Financing | 50.25M | 47.49M | 47.79M | 47.79M | 32.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -51.15M | -50.73M | -33.22M | -52.47M | -46.42M |
| Investing | -384k | -70M | 70M | -57.12M | 4.76M |
| Financing | 85.41M | 73.22M | 5.06M | 3.09M | 47.79M |
| Market Cap | 47.21M |
| Price to Earnings Ratio | -0.79 |
| Price to Sales Ratio | 47.16 |
| Price to Cash Ratio | 3.43 |
| Price to Book Ratio | 2.82 |
| Dividend Yield | - |
| Shares Outstanding | 33.48M |
| Average Volume (1 week) | 84.32k |
| Average Volume (1 Month) | 216.04k |
| 52 Week Change | -59.37% |
| 52 Week High | 3.86 |
| 52 Week Low | 1.33 |
| Spread (Intraday) | 0.01 (0.71%) |
| Company Name | Milestone Pharmaceuticals Inc |
| Address |
1111 dr.-frederik-philips blvd., suite 420 montreal, quebec H4M 2X6 |
| Website | https://www.milestonepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
